This innovative system leverages quercetin’s ability to downregulate Wnt16 and P-glycoprotein expression, thereby modifying the tumor microenvironment and reversing multidrug resistance (MDR) to bolster DOX’s effectiveness. This evidence concerns the gene WNT16 and neoplasm.